Wockhardt · NSE: WOCKPHARMA · BSE: 532300
Q4 FY20 results · Jan–Mar 2020
Wockhardt reported revenue from operations of ₹686.93 crore (down 29.8% from Q4 FY19) and net profit of ₹68.51 crore for Q4 FY20 (Jan–Mar 2020), on a consolidated basis.
| Item | Q4 FY20 | Q4 FY19 | YoY | Q3 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 686.93 | 979.13 | −29.8% | 869.15 | −21.0% |
| Other income | 13.73 | 5.42 | +153.3% | 17.20 | −20.2% |
| Total income | 700.66 | 984.55 | −28.8% | 886.35 | −20.9% |
| Profit before tax | (95.13) | (48.00) | Loss widened | 16.42 | Turned loss |
| Net profit for the period | 68.51 | (13.90) | Turned profit | 19.21 | +256.6% |
| Attributable to shareholders of the company | 48.29 | (14.47) | Turned profit | 9.63 | +401.5% |
| EPS, basic (₹) | 4.36 | (1.31) | Turned profit | 0.87 | +401.1% |
| Net margin (%) | 10.0 | -1.4 | 2.2 |
| Item | Q4 FY20 | Q4 FY19 | YoY | Q3 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 162.21 | 467.40 | −65.3% | 328.74 | −50.7% |
| Other income | 12.62 | 8.39 | +50.4% | 19.77 | −36.2% |
| Total income | 174.83 | 475.79 | −63.3% | 348.51 | −49.8% |
| Profit before tax | (150.24) | (82.73) | Loss widened | (86.86) | Loss widened |
| Net profit for the period | (78.48) | (33.52) | Loss widened | (69.84) | Loss widened |
| EPS, basic (₹) | (7.08) | (3.03) | Loss widened | (6.31) | Loss widened |
| Net margin (%) | -48.4 | -7.2 | -21.2 |
Consolidated
- Filed with BSE
- 12 May 2020, 09:09 IST
- Board meeting
- 11 May 2020
- Period
- 01 Jan 2020 to 31 Mar 2020
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 12 May 2020, 09:09 IST
- Board meeting
- 11 May 2020
- Period
- 01 Jan 2020 to 31 Mar 2020
- Review status
- Audited
- Source
- XBRL filing on BSE